Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-002173

Director bought 433 shares at an average $2.88 ($1,247)

From the SEC's structured data for this filing

Trades in this filing

Maryles Joel Michael · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-24 Purchase : show line 1 in the form +400 $2.89 $1,156 1,400 D
2022-05-24 Purchase : show line 2 in the form +33 $2.76 $91 1,433 D
Open-market purchases · 433 sh · avg $2.88 · $1,247

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-03-07 Grant or award : show line 3 in the form Option to Purchase American Depositary Shares +6,820 6,820 D
2021-04-19 Grant or award : show line 4 in the form Option to Purchase American Depositary Shares +11,884 11,884 D
Loading xslF345X03/zk2227908.xml…